Aberrant p16^INK4 expression related to clinical stage and prognosis in patients with pancreatic cancer

Biochemistry, Genetics and Molecular Biology

• P16 100%
• Protein Expression 83%
• P53 66%
• Tumor Suppressor Gene 50%
• Immunoreactivity 33%
• Immunostaining 33%
• Carcinogenesis 16%
• Ploidy 16%
• S Phase 16%
• Cell Cycle 16%
• Tumor Progression 16%
• Protein P53 16%
• Cell Cycle Regulation 16%
• Diploidy 16%

Keyphrases

• P53 Protein Expression 60%
• AgNOR 40%
• Ductal Pancreatic Adenocarcinoma 20%
• Diploidy 20%
• Pancreatic Tumorigenesis 20%
• Disease Classification 20%
• Tumor Section 20%